Browse by topic — Dr. Abdelmuhsen Abusneina

Teaching

📚 All Courses Molecular Therapeutics (MOLD-405) Cell & Molecular Biology Special Topics Biomedical Sciences Syllabi 👤 About Me 🎓 CV / Download 📄 Publications 🔬 Lab Resources ✍️ Blog ✉️ Contact 🌐 العربية

Cancer metabolism (4)

Feature · Oct 19, 2026Why a Glutaminolysis Signature Falls With PTEN Loss: Passenger Co-Deletion, Not Metabolic Regulation
Feature · Oct 19, 2026Glutamine Plus Chemotherapy for Advanced Pancreatic Cancer: A Small Phase 1 Trial Finds the Combination Feasible
Explainer · Oct 19, 2026Glutamine Addiction: Why Some Cancer Cells Depend on a Nonessential Amino Acid
Daily brief · Oct 19, 2026A New Class of Mitochondria-Targeted Compounds Induces Ferroptosis and Suppresses Tumors in Cancer Models

Glutamine (4)

Feature · Oct 19, 2026Ammonium Ions Improve Survival of Glutamine-Starved Hybridoma Cells Without Blocking Core Apoptosis Events
Feature · Oct 19, 2026MCL-1 and Apoptosis: What Obatoclax Teaches Us About Cancer Cell Death
Feature · Oct 19, 2026Glutamine Plus Chemotherapy for Advanced Pancreatic Cancer: A Small Phase 1 Trial Finds the Combination Feasible
Explainer · Oct 19, 2026Glutamine Addiction: Why Some Cancer Cells Depend on a Nonessential Amino Acid

Glutaminolysis (3)

Feature · Oct 19, 2026Why a Glutaminolysis Signature Falls With PTEN Loss: Passenger Co-Deletion, Not Metabolic Regulation
Feature · Oct 19, 2026Ammonium Ions Improve Survival of Glutamine-Starved Hybridoma Cells Without Blocking Core Apoptosis Events
Explainer · Oct 19, 2026Glutamine Addiction: Why Some Cancer Cells Depend on a Nonessential Amino Acid

Apoptosis (2)

Feature · Oct 19, 2026Ammonium Ions Improve Survival of Glutamine-Starved Hybridoma Cells Without Blocking Core Apoptosis Events
Feature · Oct 19, 2026MCL-1 and Apoptosis: What Obatoclax Teaches Us About Cancer Cell Death

Cell death (2)

Feature · Oct 19, 2026MCL-1 and Apoptosis: What Obatoclax Teaches Us About Cancer Cell Death
Daily brief · Oct 19, 2026A New Class of Mitochondria-Targeted Compounds Induces Ferroptosis and Suppresses Tumors in Cancer Models

Hybridoma cells (2)

Feature · Oct 19, 2026Ammonium Ions Improve Survival of Glutamine-Starved Hybridoma Cells Without Blocking Core Apoptosis Events
Feature · Oct 19, 2026MCL-1 and Apoptosis: What Obatoclax Teaches Us About Cancer Cell Death

Mitochondria (2)

Explainer · Oct 19, 2026Glutamine Addiction: Why Some Cancer Cells Depend on a Nonessential Amino Acid
Daily brief · Oct 19, 2026A New Class of Mitochondria-Targeted Compounds Induces Ferroptosis and Suppresses Tumors in Cancer Models

Molecular therapeutics (2)

Daily brief · Oct 20, 2026Programmable Cas13b Silences Cancer-Driving Fusion Transcripts, Including Drug-Resistant BCR::ABL1, in Cell Models
Science news · Oct 20, 2026Nobel Prize in Physiology or Medicine 2026 Honors the Light-Gated Channels Behind Optogenetics

Ammonium (1)

Feature · Oct 19, 2026Ammonium Ions Improve Survival of Glutamine-Starved Hybridoma Cells Without Blocking Core Apoptosis Events

BCL-2 family (1)

Feature · Oct 19, 2026MCL-1 and Apoptosis: What Obatoclax Teaches Us About Cancer Cell Death

Bioinformatics (1)

Feature · Oct 19, 2026Why a Glutaminolysis Signature Falls With PTEN Loss: Passenger Co-Deletion, Not Metabolic Regulation

Biomarkers (1)

Feature · Oct 19, 2026Why a Glutaminolysis Signature Falls With PTEN Loss: Passenger Co-Deletion, Not Metabolic Regulation

Chemotherapy (1)

Feature · Oct 19, 2026Glutamine Plus Chemotherapy for Advanced Pancreatic Cancer: A Small Phase 1 Trial Finds the Combination Feasible

Chronic myeloid leukemia (1)

Daily brief · Oct 20, 2026Programmable Cas13b Silences Cancer-Driving Fusion Transcripts, Including Drug-Resistant BCR::ABL1, in Cell Models

Clinical trials (1)

Feature · Oct 19, 2026Glutamine Plus Chemotherapy for Advanced Pancreatic Cancer: A Small Phase 1 Trial Finds the Combination Feasible

CRISPR (1)

Daily brief · Oct 20, 2026Programmable Cas13b Silences Cancer-Driving Fusion Transcripts, Including Drug-Resistant BCR::ABL1, in Cell Models

Drug resistance (1)

Daily brief · Oct 20, 2026Programmable Cas13b Silences Cancer-Driving Fusion Transcripts, Including Drug-Resistant BCR::ABL1, in Cell Models

Ferroptosis (1)

Daily brief · Oct 19, 2026A New Class of Mitochondria-Targeted Compounds Induces Ferroptosis and Suppresses Tumors in Cancer Models

Gene fusions (1)

Daily brief · Oct 20, 2026Programmable Cas13b Silences Cancer-Driving Fusion Transcripts, Including Drug-Resistant BCR::ABL1, in Cell Models

Immunotherapy (1)

Daily brief · Oct 19, 2026A New Class of Mitochondria-Targeted Compounds Induces Ferroptosis and Suppresses Tumors in Cancer Models

Ion channels (1)

Science news · Oct 20, 2026Nobel Prize in Physiology or Medicine 2026 Honors the Light-Gated Channels Behind Optogenetics

Lipid peroxidation (1)

Daily brief · Oct 19, 2026A New Class of Mitochondria-Targeted Compounds Induces Ferroptosis and Suppresses Tumors in Cancer Models

MYC (1)

Explainer · Oct 19, 2026Glutamine Addiction: Why Some Cancer Cells Depend on a Nonessential Amino Acid

Neuroscience (1)

Science news · Oct 20, 2026Nobel Prize in Physiology or Medicine 2026 Honors the Light-Gated Channels Behind Optogenetics

Nobel Prize (1)

Science news · Oct 20, 2026Nobel Prize in Physiology or Medicine 2026 Honors the Light-Gated Channels Behind Optogenetics

Obatoclax (1)

Feature · Oct 19, 2026MCL-1 and Apoptosis: What Obatoclax Teaches Us About Cancer Cell Death

Optogenetics (1)

Science news · Oct 20, 2026Nobel Prize in Physiology or Medicine 2026 Honors the Light-Gated Channels Behind Optogenetics

Pancreatic cancer (1)

Feature · Oct 19, 2026Glutamine Plus Chemotherapy for Advanced Pancreatic Cancer: A Small Phase 1 Trial Finds the Combination Feasible

PTEN (1)

Feature · Oct 19, 2026Why a Glutaminolysis Signature Falls With PTEN Loss: Passenger Co-Deletion, Not Metabolic Regulation

RNA therapeutics (1)

Daily brief · Oct 20, 2026Programmable Cas13b Silences Cancer-Driving Fusion Transcripts, Including Drug-Resistant BCR::ABL1, in Cell Models

TCGA (1)

Feature · Oct 19, 2026Why a Glutaminolysis Signature Falls With PTEN Loss: Passenger Co-Deletion, Not Metabolic Regulation

← Back to the blog